Pulmonology

Resource Center

chest annual meeting

Research Summaries

Research Summary

Research Summary

Effect of Dual PDE3/4 Inhibitor Amixetrine on Exacerbation Rate and Risk in Moderate to Severe COPD

12/22/2025

Anthony Calabro, MA

A pooled analysis of two phase 3 ENHANCE trials evaluated whether the inhaled dual phosphodiesterase 3 and 4 inhibitor antifeminine reduces chronic obstructive pulmonary disease exacerbation frequency and...

12/22/2025

Conference Coverage

Conference Coverage

Comorbid COPD Increases Readmission Risk After Acute Chest Syndrome in Adults with Sickle Cell Disease

12/08/2025

Anthony Calabro, MA

A new national analysis provides clinicians with evidence on how chronic obstructive pulmonary disease affects post-discharge outcomes in adults with sickle cell disease hospitalized for acute chest...

12/08/2025

Research Summary

Research Summary

Anti–IL-5 Therapy Reduces Severe Exacerbations in Belgian Asthma Cohort with and without COPD

11/26/2025

Anthony Calabro, MA

A nationwide Belgian cohort study found that biologic therapy targeting interleukin (IL) 5 reduced moderate and severe exacerbations among adults with severe eosinophilic asthma, including those with...

11/26/2025

Research Summary

Research Summary

Immune Profiling Identifies Emphysema-Linked COPD Subtype Independent of GOLD Stage

11/25/2025

Anthony Calabro, MA

Researchers in Graz, Austria, used machine learning and multiomics immune profiling to uncover a distinct chronic obstructive pulmonary disease subtype tied to emphysema severity and reduced gas exchange....

11/25/2025

Research Summary

Research Summary

Bivalent RSV Vaccine Lowers Cardiorespiratory Hospitalizations in Older Adults

11/19/2025

Kate Young

In a nationwide Danish trial of more than 130,000 adults aged 60 years and older, a single dose of the bivalent RSV prefusion F protein vaccine reduced all-cause cardiorespiratory hospitalizations by nearly...

11/19/2025

April 2026

Current Issue

April 2026